The scope of pharmacy practice in Canada has undergone a quiet but significant transformation over the past two decades. This evolution is now showing up in licensing examinations. If you are preparing for your OSCE, pharmacist prescribing is a content area you need to understand, not just clinically, but jurisdictionally.
Because here is the thing that trips candidates up: what you are authorized to do as a pharmacist depends entirely on where you are practicing.
A Pan-Canadian Snapshot: The Range Is Wide
Canada has 13 provinces and territories, and each has its own pharmacy regulatory framework. The Canadian Pharmacists Association (CPhA) maintains a national prescribing authority comparison chart, and the variation it captures is striking.
At one end of the spectrum sits Alberta, which has the most expansive pharmacist prescribing authority in the country. Under the Health Professions Act and through the Alberta College of Pharmacists, Alberta pharmacists with Additional Prescribing Authorization (APA) can independently prescribe any Schedule 1 drug, with no restriction to a defined list of conditions. They can also order laboratory tests (with a practitioner ID number), adapt prescriptions including therapeutic substitutions, and in emergency situations, prescribe when no other authorized prescriber is available. This level of authority, particularly the ability to initiate therapy for virtually any condition, is unmatched anywhere else in Canada.
At the other end sits Nunavut, which until very recently had the least comprehensive pharmacy legislative framework in the country. Nunavut's pharmacy legislation dated back decades and had seen minimal modernization. Pharmacists there were largely limited to dispensing, and lacked the legal basis to administer vaccines or prescribe for minor ailments, activities that pharmacists in most other jurisdictions have been doing for years. This gap became especially visible during the COVID-19 pandemic, when the territory could not legally deploy pharmacists to administer vaccines.
In recognition of this, Nunavut passed a brand-new Pharmacy Professions Act in early 2025, which for the first time allows Nunavut pharmacists to administer vaccines and prescribe for minor ailments. Regulations are still being drafted and are expected to take up to 18 months to fully roll out, meaning the on-the-ground reality is still catching up to the legislation.
Between these two poles, every other province and territory falls somewhere along the continuum. Most jurisdictions now permit pharmacists to renew or adapt prescriptions for continuity of care, prescribe for a defined list of minor ailments, and administer injections and vaccines with appropriate training. But the specific conditions covered, the documentation requirements, the notification obligations, and the funding models differ in meaningful ways from one college to the next.
What Is Consistent Across Canada
Despite the jurisdictional variation, there are core principles and clinical expectations that apply broadly across Canadian pharmacy practice. These are the foundations that your OSCE is most likely to test.
1. Assess Before You Prescribe
Regardless of province, no pharmacist should initiate, adapt, or renew a prescription without first conducting a thorough patient assessment. This means reviewing the patient's medication history, past and current medical conditions, allergies and intolerances, relevant physical characteristics, and any available lab or point-of-care results. It means evaluating the risks and benefits of the proposed therapy for this specific patient. And it means identifying any contraindications, precautions, or drug therapy problems before acting. In an OSCE context, rushing past this step, even if your clinical answer is correct, is a failure of process.
2. Assess Your Own Competency
Every Canadian pharmacy regulatory framework includes some version of this requirement: you must only prescribe when you have sufficient knowledge, skill, and judgment to do so safely. This is not just a formality. If you identify a gap, a condition you are unfamiliar with, a drug interaction you are unsure about, you have a professional obligation to address that gap before prescribing, or to refer the patient to someone better positioned to help.
3. Obtain Informed Consent
Before initiating a prescription, the patient must provide informed consent. This means they have received information about the nature of the proposed treatment, its expected benefits, potential risks or side effects, available alternatives, and the consequences of not treating. Consent may be expressed verbally or in writing, or in some circumstances implied by the patient's conduct. There is no universal minimum age of consent across Canada; this is governed by provincial legislation and context.
4. Prescribe Accurately and Completely
A valid prescription across all jurisdictions must include the patient's identifying information, the drug name, strength, and quantity, directions for use (dose, frequency, route, special instructions), and the prescriber's identifying information including their registration or license number, contact details, and the date. Missing any of these elements is not a minor oversight; it is an incomplete prescription.
5. Communicate the Patient's Right to Choose
One principle that appears consistently in Canadian pharmacy practice standards is this: when a pharmacist writes a prescription, the patient is entitled to take that prescription to any pharmacy of their choice for dispensing. The pharmacist must communicate this. It is not optional.
6. Document Thoroughly
Documentation is not just administrative housekeeping; it is a professional and, in most jurisdictions, a legislative requirement. When prescribing, you must document your patient assessment, the clinical rationale for your decision, any test results considered, confirmation that informed consent was received, and your follow-up and monitoring plan. If you adapted or renewed an existing prescription, documentation of the original prescription and prescriber information is also required.
7. Notify the Prescriber and Primary Care Provider
Across Canadian jurisdictions, pharmacists are expected to notify the original prescriber and/or the patient's primary care provider when initiating or renewing a prescription, within a reasonable timeframe. The threshold for notification when adapting a prescription is generally tied to clinical significance; if the adaptation is clinically meaningful in the patient's circumstances, notify. If the patient has no primary care provider, document this clearly and advise the patient accordingly.
The Limits: What Pharmacists Generally Cannot Do
While prescribing authority has expanded, there are clear boundaries that remain consistent across most of Canada.
- • Controlled substances: Pharmacists in most jurisdictions cannot independently initiate prescriptions for narcotics, controlled drugs, or targeted substances. The ability to adapt or renew controlled substance prescriptions is more nuanced and jurisdiction-specific. A federal CDSA class exemption has allowed some controlled substance prescription management during and after the pandemic, but this is time-limited and subject to change.
- • Therapeutic substitution in adaptation: Adapting a prescription means changing the dose, formulation, regimen, or route of administration. It does not mean substituting a chemically different drug, even a therapeutically equivalent one. Alberta is an exception to this, where therapeutic substitution is permitted under certain frameworks, but this is not the norm nationally.
- • Prescribing beyond your competency: No regulatory framework in Canada authorizes a pharmacist to prescribe in an area where they lack sufficient knowledge or training. Self-assessment is a professional obligation, not just a best practice.
The OSCE Implication: Jurisdiction Is a Clinical Skill
This is the most important takeaway for OSCE candidates: knowing your scope is part of the clinical answer. If you are presented with a case involving expanded scope practice, a patient requesting a minor ailment prescription, a continuity-of-care renewal, or an adaptation request, the first question is not what drug should I prescribe? The first question is: Am I authorized to do this in the jurisdiction where I am practicing?
Getting the pharmacotherapy right but acting outside your authorized scope is a real failure mode, both in examinations and in practice. Provincial and territorial regulatory bodies are the authoritative source on what is permitted in each jurisdiction. The CPhA national comparison chart is a useful orientation tool, but always verify against your college's current standards.
Looking Ahead: The Landscape Continues to Shift
The regulatory landscape for pharmacist prescribing is not static. Nunavut's new legislation is one example. Quebec's adoption of Bill 67 in November 2024, which expanded independent prescribing of Schedule 1 medications under certain conditions, is another. The direction of travel across Canada is clearly toward broader pharmacist scope, but the pace and the specifics remain province by province. As this area of practice evolves, so will the expectations in licensing examinations. At Simulabs Technologies, we are building and continuously expanding our case library in Dosette.ca, our AI-powered OSCE preparation platform, to keep pace with the evolving regulatory environment across provinces. This is an area to watch and to prepare for, even if the specific OSCE cases are still emerging.
The Bottom Line
Pharmacist prescribing in Canada is real, it is growing, and it is being tested. The clinical workflow, assess the patient, assess your competency, obtain informed consent, prescribe accurately, communicate clearly, document everything, notify the right people, is broadly consistent from coast to coast. What varies is the scope of what you are authorized to prescribe, and in which circumstances.
Know the universal principles. Know your jurisdiction. Prescribe with confidence.
References
Ontario College of Pharmacists, Pharmacist Prescribing: Initiating, Adapting and Renewing Prescriptions Guideline (v7.00, October 2024); Alberta Health Services, Framework for Implementation of Expanded Scope of Practice for Pharmacists; Canadian Pharmacists Association, Pharmacist Prescribing Authority Chart (updated February 2025); Nunavut Legislative Assembly, Pharmacy Professions Act (2025); Nunatsiaq News, Nunavut legislature approves law allowing pharmacists to give vaccines (May 2025)
Hassan Torkamandi, PharmD, RPh
CEO, Simulabs Technologies Inc.



